SCHEMBL8970143

SCHEMBL8970143

O=C1c2ccccc2C(=O)N1CCCC1CCCN(Cc2ccccc2)C1

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6338164 0.82 ACHE (0.59) ACHE
SCHEMBL16528509 0.80 SMN1; SMN2 (0.54) ACHE
SCHEMBL28952283 0.79 CYP2D6 (0.57) ACHE
SCHEMBL13596991 0.78 CYP2D6 (0.56) ACHE
SCHEMBL17117470 0.78 ACHE (0.59) ACHE
SCHEMBL21609732 0.78 ACHE (0.59) ACHE
SCHEMBL21609729 0.78 ACHE (0.59) ACHE
SCHEMBL5463699 0.77 ALDH1A1 (0.55) ACHE
SCHEMBL8330129 0.77 CYP2D6 (0.49) ACHE
SCHEMBL21812109 0.76 CTSS (0.61) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5480892-A SIGMA RECEPTOR ANTAGONISTS; TREATMENT OF PHYSIOLOGICAL OR DRUG INDUCED PSYCHOSIS AND DYSKINESIA THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-01-02 US disclosed
US-5356906-A (N-phthalimidoalkyl) piperidines useful as treatments for psychosis THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-10-18 US disclosed
WO-1993022310-A1 (N-PHTHALIMIDOALKYL)PIPERIDINES FOR THE TREATMENT OF PSYCHOSES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-11-11 WO disclosed
EP-0497843-A4 (N-PHTHALIMIDOALKYL) PIPERIDINES 1992-09-23 EP disclosed
EP-0497843-A1 (N-PHTHALIMIDOALKYL) PIPERIDINES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-08-12 EP disclosed
WO-1991006297-A1 (N-PHTHALIMIDOALKYL) PIPERIDINES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1991-05-16 WO disclosed